PainReform Ltd. (PRFX)
USD 2.02
(1.51%)
USD 2.02
(1.51%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -9.34 Million USD | -6.28% |
| 2022 | -8.79 Million USD | -21.34% |
| 2021 | -7.24 Million USD | -78.78% |
| 2020 | -4.05 Million USD | -122.69% |
| 2019 | -1.82 Million USD | -119.81% |
| 2018 | -828 Thousand USD | 60.38% |
| 2017 | -2.09 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -5.5 Million USD | -12.57% |
| 2024 Q2 | -7.31 Million USD | -32.8% |
| 2023 Q2 | -2.18 Million USD | 0.73% |
| 2023 Q1 | -2.19 Million USD | 30.14% |
| 2023 FY | -9.34 Million USD | -6.28% |
| 2023 Q4 | -4.89 Million USD | -13686.11% |
| 2023 Q3 | 36 Thousand USD | 101.65% |
| 2022 Q3 | -2.12 Million USD | -18.81% |
| 2022 Q2 | -1.78 Million USD | -5.43% |
| 2022 Q1 | -1.69 Million USD | 2.25% |
| 2022 FY | -8.79 Million USD | -21.34% |
| 2022 Q4 | -3.14 Million USD | -48.21% |
| 2021 FY | -7.24 Million USD | -78.78% |
| 2021 Q2 | -1.7 Million USD | 16.66% |
| 2021 Q3 | -1.77 Million USD | -4.12% |
| 2021 Q4 | -1.73 Million USD | 2.15% |
| 2021 Q1 | -2.04 Million USD | -103.9% |
| 2020 FY | -4.05 Million USD | -122.69% |
| 2020 Q4 | -1 Million USD | 8.08% |
| 2020 Q1 | -1.29 Million USD | -80.75% |
| 2020 Q2 | -667 Thousand USD | 48.53% |
| 2020 Q3 | -1.08 Million USD | -63.27% |
| 2019 Q3 | -717 Thousand USD | -47.08% |
| 2019 FY | -1.82 Million USD | -119.81% |
| 2019 Q1 | -487.5 Thousand USD | -2.74% |
| 2019 Q2 | -487.5 Thousand USD | 0.0% |
| 2019 Q4 | -717 Thousand USD | 0.0% |
| 2018 Q1 | -462.5 Thousand USD | 0.0% |
| 2018 Q2 | -462.5 Thousand USD | 0.0% |
| 2018 Q3 | -474.5 Thousand USD | -2.59% |
| 2018 FY | -828 Thousand USD | 60.38% |
| 2018 Q4 | -474.5 Thousand USD | 0.0% |
| 2017 FY | -2.09 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 119.404% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -201.562% |
| Embecta Corp. | 70.4 Million USD | 113.273% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 122.271% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -107.366% |
| SCYNEXIS, Inc. | 67.04 Million USD | 113.938% |
| Journey Medical Corporation | -3.85 Million USD | -142.512% |
| Safety Shot Inc | -15.08 Million USD | 38.05% |
| Alpha Teknova, Inc. | -36.78 Million USD | 74.595% |
| Bright Green Corporation | -13.12 Million USD | 28.822% |
| Procaps Group, S.A. | 42.54 Million USD | 121.965% |
| Alvotech | -551.73 Million USD | 98.306% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 149.758% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -18.729% |
| Cosmos Health Inc. | -18.54 Million USD | 49.608% |
| Dynavax Technologies Corporation | -6.38 Million USD | -46.251% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 95.534% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 93.31% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -107.366% |
| Theratechnologies Inc. | -23.95 Million USD | 60.997% |
| Harrow Health, Inc. | -24.41 Million USD | 61.722% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -93.257% |
| Biofrontera Inc. | -20.13 Million USD | 53.584% |
| DURECT Corporation | -27.62 Million USD | 66.174% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 810.03% |
| Cronos Group Inc. | -73.96 Million USD | 87.367% |
| OptiNose, Inc. | -35.48 Million USD | 73.666% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 99.068% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 77.857% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 139.07% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 288.959% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 6012.689% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -48.806% |
| Radius Health, Inc. | -25.79 Million USD | 63.77% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -51.613% |
| ProPhase Labs, Inc. | -16.78 Million USD | 44.321% |
| Phibro Animal Health Corporation | 2.41 Million USD | 486.755% |
| Procaps Group S.A. | 42.54 Million USD | 121.965% |
| TherapeuticsMD, Inc. | -10.27 Million USD | 9.087% |
| Viatris Inc. | 54.7 Million USD | 117.082% |
| Rockwell Medical, Inc. | -8.43 Million USD | -10.724% |
| Aytu BioPharma, Inc. | -15.84 Million USD | 41.025% |
| SIGA Technologies, Inc. | 68.06 Million USD | 113.727% |
| Tilray Brands, Inc. | -244.98 Million USD | 96.186% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 177.782% |
| Shineco, Inc. | -22.44 Million USD | 58.377% |
| PetIQ, Inc. | 2.13 Million USD | 538.48% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -117.21% |
| Incannex Healthcare Limited | -18.45 Million USD | 49.38% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 103.742% |
| Alimera Sciences, Inc. | -20.13 Million USD | 53.586% |
| Silver Spike Investment Corp. | 7.34 Million USD | 227.301% |
| Assertio Holdings, Inc. | -331.94 Million USD | 97.185% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -41.732% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -14.465% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | 47.796% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 53.413% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 94.17% |
| Hempacco Co., Inc. | -13.12 Million USD | 28.813% |
| Talphera, Inc. | -18.39 Million USD | 49.209% |
| Alvotech | -551.73 Million USD | 98.306% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 126.216% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 102.86% |
| Currenc Group, Inc. | -15.3 Million USD | 38.954% |
| Kamada Ltd. | 8.28 Million USD | 212.796% |
| Indivior PLC | 2 Million USD | 567.2% |
| Evoke Pharma, Inc. | -7.79 Million USD | -19.913% |
| Flora Growth Corp. | -57.03 Million USD | 83.617% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 53.413% |
| Evolus, Inc. | -61.68 Million USD | 84.852% |
| HUTCHMED (China) Limited | 100.78 Million USD | 109.272% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 106.793% |
| Akanda Corp. | -32.27 Million USD | 71.049% |